BioAge Labs, Inc. Common Stock (BIOA) is a publicly traded Healthcare sector company. As of May 20, 2026, BIOA trades at $16.13 with a market cap of $681.90M and a P/E ratio of -6.84. BIOA moved -1.41% today. Year to date, BIOA is +27.59%; over the trailing twelve months it is +315.48%. Its 52-week range spans $2.88 to $26.62. Analyst consensus is buy with an average price target of $47.83. Rallies surfaces BIOA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
BioAge Labs, Inc. Common Stock (BIOA) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. BIOA moved -1.41% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $16.13 |
| Market Cap | $681.90M |
| P/E Ratio | -6.84 |
| EPS | $-2.40 |
| Dividend Yield | 0.00% |
| 52-Week High | $26.62 |
| 52-Week Low | $2.88 |
| Volume | 89.27K |
| Avg Volume | 0 |
| Revenue (TTM) | $10.32M |
| Net Income | $-89.93M |
| Gross Margin | 0.00% |
7 analysts cover BIOA: 0 strong buy, 5 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $47.83.